美股異動丨恩智浦半導體盤前續漲近2% 近6日累計升幅達17% 獲多家大行唱好
昨日大漲超7%恩智浦(NXPI.US)盤前續漲1.76%,該股近6日累計升幅達17%。消息上,近日該股持續獲大行唱好:Truist將恩智浦的目標價從245美元上調至258美元,維持“買入”評級;花旗將恩智浦半導體評級上調至買進,目標價290美元;摩根士丹利將恩智浦半導體的評級從“中性”上調至“增持”,目標價從231美元上調至257美元。值得注意的是,恩智浦日前宣佈全球裁員計劃,應對市場需求下滑與經濟不確定性。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.